Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Mounjaro, a weekly injection, targets GIP and GLP-1 hormones to enhance insulin release and appetite regulation, aiding ...

In an interview with 'Self,' influencer Remi Bader opened up about her difficult experience with the weight loss drug Ozempic ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...

In the past year, treatments such as Wegovy, Mounjaro and Zepbound have become household names. But there are many questions ...

Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.

In a recent video, Amy Schumer opened up about her experiences with weight loss medications, particularly Mounjaro and Ozempic, sparking discussions on the efficacy and side effects of these drugs.

JM Financial is bullish on Mounjaro's success in India, citing its price advantage, higher efficiency and the country's large ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Equinox's GLP-1 protocol is considered a framework for people taking the drugs, one that addresses workout intensity, ...